SEP 8, 2026 · PHASE 1 TRIAL
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
ClinicalTrials.gov
This is a Phase 1 study registration with no reported results, designed to characterize drug–drug interaction pharmacokinetics between an investigational agent and oral contraceptives in a small, defined population.
Reported
Planned enrollment34
Study phasePhase 1
Primary outcome measure 1AUC(0-inf) of Ethinyl Estradiol and Levonor…